273 related articles for article (PubMed ID: 6295008)
21. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.
Moss DJ; Misko IS; Burrows SR; Burman K; McCarthy R; Sculley TB
Nature; 1988 Feb; 331(6158):719-21. PubMed ID: 2830541
[TBL] [Abstract][Full Text] [Related]
22. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
Tosato G; Straus S; Henle W; Pike SE; Blaese RM
J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
Niedobitek G; Agathanggelou A; Herbst H; Whitehead L; Wright DH; Young LS
J Pathol; 1997 Jun; 182(2):151-9. PubMed ID: 9274524
[TBL] [Abstract][Full Text] [Related]
24. Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems.
Schooley RT; Haynes BF; Grouse J; Payling-Wright C; Fauci AS; Dolin R
Blood; 1981 Mar; 57(3):510-7. PubMed ID: 6257313
[TBL] [Abstract][Full Text] [Related]
25. T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus.
Rickinson AB
Prog Brain Res; 1983; 59():189-202. PubMed ID: 6320264
[No Abstract] [Full Text] [Related]
26. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.
White CA; Cross SM; Kurilla MG; Kerr BM; Schmidt C; Misko IS; Khanna R; Moss DJ
Virology; 1996 May; 219(2):489-92. PubMed ID: 8638417
[TBL] [Abstract][Full Text] [Related]
27. B lymphocytopenia in infectious mononucleosis.
Sumaya CV; Keightley RG
Clin Exp Immunol; 1981 Feb; 43(2):298-301. PubMed ID: 6268336
[TBL] [Abstract][Full Text] [Related]
28. The biology and chemistry of Epstein-Barr virus.
Kieff E; Dambaugh T; Heller M; King W; Cheung A; van Santen V; Hummel M; Beisel C; Fennewald S; Hennessy K; Heineman T
J Infect Dis; 1982 Oct; 146(4):506-17. PubMed ID: 6288806
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
30. An Epstein-Barr virus-associated superantigen.
Sutkowski N; Palkama T; Ciurli C; Sekaly RP; Thorley-Lawson DA; Huber BT
J Exp Med; 1996 Sep; 184(3):971-80. PubMed ID: 9064357
[TBL] [Abstract][Full Text] [Related]
31. Detection of Epstein-Barr virus-coded antigens in lymphocytes isolated from defined patient samples.
Veltri RW; McClung JE; Sprinkle PM
IARC Sci Publ (1971); 1978; (24 Pt 2):729-32. PubMed ID: 221395
[TBL] [Abstract][Full Text] [Related]
32. [Expression of interleukin 2 receptors in in vivo Epstein-Barr virus transformed B lymphocytes].
Becker H; Helmke K; Federlin K
Immun Infekt; 1988 Feb; 16(1):21-2. PubMed ID: 2834287
[TBL] [Abstract][Full Text] [Related]
33. A human monoclonal autoantibody isolated from a patient with infectious mononucleosis reactive with both self antigens and Epstein-Barr virus nuclear antigen (EBNA).
Garzelli C; Pacciardi A; Carmignani M; Conaldi G; Basolo F; Falcone G
Immunol Lett; 1989 Sep; 22(3):211-6. PubMed ID: 2478456
[TBL] [Abstract][Full Text] [Related]
34. Infectious mononucleosis: model for self-limiting lymphoproliferation.
Carter RL
Lancet; 1975 Apr; 1(7911):846-9. PubMed ID: 48066
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts.
Thorley-Lawson DA; Schooley RT; Bhan AK; Nadler LM
Cell; 1982 Sep; 30(2):415-25. PubMed ID: 6291768
[TBL] [Abstract][Full Text] [Related]
36. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
37. Cells containing Epstein--Barr nuclear antigen (EBNA) in peripheral blood.
Gergely L; Czeglédy J; Váczi L; Szalka A; Berényi E
Acta Microbiol Acad Sci Hung; 1979; 26(1):41-5. PubMed ID: 225932
[TBL] [Abstract][Full Text] [Related]
38. The Epstein-Barr virus:host balance in acute infectious mononucleosis patients receiving acyclovir anti-viral therapy.
Yao QY; Ogan P; Rowe M; Wood M; Rickinson AB
Int J Cancer; 1989 Jan; 43(1):61-6. PubMed ID: 2536008
[TBL] [Abstract][Full Text] [Related]
39. HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells.
Rickinson AB; Wallace LE; Epstein MA
Nature; 1980 Feb; 283(5750):865-7. PubMed ID: 6244495
[TBL] [Abstract][Full Text] [Related]
40. Letter: Epstein-Barr virus and infectious mononucleosis.
Royston I
Lancet; 1973 Nov; 2(7838):1152. PubMed ID: 4128043
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
